DARZALEX SC is contraindicated in patients with a history of severe hypersensitivity to daratumumab, hyaluronidase or any of the components of the formulation [see Hypersensitivity and Other Administration Reactions under Precautions and Postmarketing Experience under Adverse Reactions].
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
